Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia
      QxMD      Google Scholar   
Citation:
Innovation (Camb) vol 5 (6)
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-internal-user
Status:
Presented/Published
Citation Status:
Received
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
15
Parents:
3826  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171, R01LM013879, R01CA262496, R01CA284595, R01CA283574, UG1CA233327, UG1CA233331, UG1CA233338, UG1CA233339, R35CA197734, P30CA016058  
Corr. Author:
 
Authors:
                                         
Networks:
LAPS-IL057, LAPS-MO011, LAPS-OH007, OH070   
Study
Alliance-A152010
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-10503, CALGB-10603, CALGB-19808, CALGB-20202, CALGB-8461, CALGB-8525, CALGB-8721, CALGB-9222, CALGB-9621
Phases:
N/A, 1, 2, 3, N/A
Keywords: